Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
752 results
  1. Excluded Studies - Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK246888
    ... Urruzola J, et al. Riesgo de invasión en carcinoma in situ de mama diagnosticado por biopsia ... breast cancer]. Zhonghua Zhong Liu Za Zhi. 2012 Oct; ...
  2. Breast Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65744
    ... HS, et al.: Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. N Engl J Med 379 (22): ... et al.: Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast ... patients with advanced breast cancer treated with doxorubicin-containing therapy. J ...
  3. Genetics of Breast and Gynecologic Cancers (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65767
    ... recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non- ...
  4. pdf2017MeshTreesWithChangesShown.pdf 
    https://www.nlm.nih.gov/.../2017MeshTreesWithChangesShown.pdf
    ... In Situ Breast Neoplasms, Male Carcinoma, Ductal, Breast Carcinoma, Lobular Hereditary Breast and Ovarian Cancer Syndrome Inflammatory Breast Neoplasms Unilateral Breast Neoplasms Triple Negative Breast Neoplasms Digestive System Neoplasms Biliary Tract Neoplasms ...
  5. Articles Excluded at Full-Text Screening by Reason - Progression-Free Survival: What Does It Mean for Psychological ... 
    https://www.ncbi.nlm.nih.gov/books/NBK137765
    ... 772. Efficacy of Biological Agents (BA) in metastatic Triple Negative Breast ... cell carcinoma: Indirect comparison analysis. Leung HW, Chan AL. Level: ...
  6. 2019New_Mesh_Tree_Hierarchy.txt 
    https://www.nlm.nih.gov/.../download/2019New_Mesh_Tree_Hierarchy.txt
    ... 390 Carcinoma, Ductal, Breast C04.588.180.437 Carcinoma, Lobular C04.588.180.483 Hereditary Breast and Ovarian Cancer Syndrome C04.588.180.576 Inflammatory Breast Neoplasms C04.588.180.788 Triple Negative Breast Neoplasms C04.588.180.800 Unilateral Breast ...
  7. pdf2016MeshTree.pdf 
    https://www.nlm.nih.gov/mesh/2016/download/2016MeshTree.pdf
    ... 260...........................................Breast Neoplasms, ... System Neoplasms ...
  8. Detailed Methods - Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA1/2-Related Cancer in Women: A ... 
    https://www.ncbi.nlm.nih.gov/books/NBK545871
    ... for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ. Cancer. 2012 Mar ... al. Outcome of triple-negative breast cancer in patients with or without deleterious BRCA ...
  9. Childhood Breast Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK547383
    ... adolescents and young adult (AYA) patients had more triple-negative breast cancer (TNBC) or HER2-positive (HER2+) cancer than did adult patients. In addition, AYA patients aged 15 to 29 years had more advanced disease and TNBC or HER2+ disease than did ...
  10. Breast Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65969
    ... being studied for the treatment of patients with triple-negative breast cancer. Talazoparib is a PARP inhibitor used to treat patients with mutations in the BRCA1 or BRCA2 genes and HER2 negative breast cancer that is locally advanced or has spread to other parts of the ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last